18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan. It's Value Confirmed by a Bicentric Experience

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|9|3|228-234

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.9, Iss.3, 2016-12, pp. : 228-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diagnostic and Prognostic Value of 18F-FDG PET/CT in Male Breast Cancer: Results From a Bicentric Population

By  

Current Radiopharmaceuticals, Vol. 9, Iss. 2, 2016-08 ,pp. : 169-177

Bentham Science Publishers

Access to resources Recommend Favorite

Increased [11C]Choline Uptake in Bronchioloalveolar Cell Carcinoma with Negative [18F]FDG Uptake. A PET/CT and Pathology Study

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 2, 2008-05 ,pp. : 62-64

Bentham Science Publishers

Access to resources Recommend Favorite

Thyroglobulin Autoantibodies as Surrogate Biomarkers in the Management of Patients with Differentiated Thyroid Carcinoma

By  

Current Medicinal Chemistry, Vol. 21, Iss. 32, 2014-10 ,pp. : 3687-3692

Bentham Science Publishers

Access to resources Recommend Favorite

Risk stratification in patients with advanced-stage breast cancer by pretreatment [18F]FDG PET/CT

By  

Cancer, Vol. 121, Iss. 22, 2015-11 ,pp. : 3965-3974

Blackwell Publishing

Access to resources Recommend Favorite

18F-DOPA and 18F-FDG PET/CT, Scintigraphic Localization and Radioguided Surgery of Recurrent Medullary Thyroid Cancer: Two Case Reports

By  

Current Radiopharmaceuticals, Vol. 7, Iss. 2, 2014-12 ,pp. : 133-137

Bentham Science Publishers

Access to resources Recommend Favorite